Peter Douwe Van Der Meer
#162,164
Most Influential Person Now
Peter Douwe Van Der Meer's AcademicInfluence.com Rankings
Peter Douwe Van Der Meerpolitical-science Degrees
Political Science
#2994
World Rank
#3507
Historical Rank
Peter Douwe Van Der Meermedical Degrees
Medical
#3281
World Rank
#3744
Historical Rank
Cardiology
#341
World Rank
#352
Historical Rank
Download Badge
Political Science Medical
Peter Douwe Van Der Meer's Degrees
- PhD Political Science University of Amsterdam
- Masters Political Science University of Amsterdam
Why Is Peter Douwe Van Der Meer Influential?
(Suggest an Edit or Addition)Peter Douwe Van Der Meer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. (2016) (7627)
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2016) (6692)
- 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. (2016) (5626)
- Anemia and mortality in heart failure patients a systematic review and meta-analysis. (2008) (650)
- Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction (2010) (539)
- Iron deficiency in chronic heart failure: an international pooled analysis. (2013) (519)
- Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study (2010) (411)
- Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. (2005) (271)
- Treating oxidative stress in heart failure: past, present and future (2018) (269)
- Correction: Corrigendum: Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis (2015) (268)
- Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial. (2015) (266)
- Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency (2017) (255)
- Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension (2016) (234)
- Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. (2007) (230)
- MicroRNAs in heart failure: from biomarker to target for therapy (2016) (222)
- Generation of Functional Ventricular Heart Muscle from Mouse Ventricular Progenitor Cells (2009) (213)
- Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. (2004) (187)
- Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. (2006) (185)
- Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function (2018) (185)
- Timing of Erythropoietin Treatment for Cardioprotection in Ischemia/Reperfusion (2004) (178)
- Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis (2014) (170)
- Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction. (2018) (167)
- Heart Failure Stimulates Tumor Growth by Circulating Factors (2018) (167)
- Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy (2016) (165)
- The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. (2013) (162)
- Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. (2014) (161)
- Signature of circulating microRNAs in patients with acute heart failure (2016) (152)
- Levels of Hematopoiesis Inhibitor N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Partially Explain the Occurrence of Anemia in Heart Failure (2005) (151)
- Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction (2017) (150)
- Refinements in stress echocardiographic techniques improve inter-institutional agreement in interpretation of dobutamine stress echocardiograms. (2002) (150)
- Cardio-Oncology Services: rationale, organization, and implementation. (2018) (149)
- Erythropoietin in cardiovascular diseases. (2004) (149)
- ACC/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison. (2019) (147)
- Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study. (2014) (144)
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). (2022) (144)
- Erythropoietin treatment in patients with chronic heart failure: a meta-analysis (2009) (140)
- Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume. (2017) (137)
- Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS‐9) in heart failure patients: results from a phase 3 randomized, double‐blind, placebo‐controlled trial (2015) (137)
- Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM) (2017) (134)
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). (2022) (128)
- Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1&agr; and LDHA (2018) (122)
- Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients (2018) (114)
- Xanthine oxidoreductase activity in perfused hearts of various species, including humans. (1990) (114)
- Intracellular sodium during ischemia and calcium-free perfusion: a 23Na NMR study. (1991) (108)
- The LifeLines Cohort Study: Prevalence and treatment of cardiovascular disease and risk factors. (2017) (106)
- Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. (2018) (105)
- Cancer and heart disease: associations and relations (2019) (91)
- Hemoglobin levels and 30-day mortality in patients after myocardial infarction. (2005) (87)
- Long‐term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy (2018) (87)
- Adenosine as adjunct to potassium cardioplegia: effect on function, energy metabolism, and electrophysiology. (1990) (83)
- Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction. (2017) (82)
- Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice (2018) (82)
- Optimizing clinical use of biomarkers in high‐risk acute heart failure patients (2016) (82)
- Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure. (2013) (81)
- Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients. (2008) (80)
- Waist‐to‐hip ratio and mortality in heart failure (2018) (79)
- Sex differences in cardiomyopathies (2014) (77)
- Echocardiographic estimation of left ventricular and pulmonary pressures in patients with heart failure and preserved ejection fraction: a study utilizing simultaneous echocardiography and invasive measurements (2017) (73)
- Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci (2019) (72)
- Renin–Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data (2017) (72)
- Neurohormonal and clinical sex differences in heart failure. (2013) (71)
- Diuretic response in acute heart failure-an analysis from ASCEND-HF. (2015) (70)
- 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. (2022) (68)
- What have we learned about heart failure with mid‐range ejection fraction one year after its introduction? (2017) (68)
- A Systematic Review and Network-Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction (2021) (66)
- Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure (2016) (65)
- Fibrosis Marker Syndecan-1 and Outcome in Patients With Heart Failure With Reduced and Preserved Ejection Fraction (2014) (64)
- The additive burden of iron deficiency in the cardiorenal–anaemia axis: scope of a problem and its consequences (2014) (63)
- Selenium and outcome in heart failure (2019) (62)
- Endogenous Erythropoietin and Outcome in Heart Failure (2010) (62)
- Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2020) (61)
- Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations (2017) (60)
- The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy. (2005) (59)
- Integrated Analysis of Contractile Kinetics, Force Generation, and Electrical Activity in Single Human Stem Cell-Derived Cardiomyocytes (2015) (59)
- The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction. (2012) (59)
- Potassium and the use of renin–angiotensin–aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT‐CHF (2018) (58)
- Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry. (2020) (57)
- Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. (2021) (57)
- Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use (2019) (56)
- Risk and Temporal Changes of Heart Failure Among 5‐Year Childhood Cancer Survivors: a DCOG‐LATER Study (2018) (55)
- Finerenone: third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease (2015) (55)
- Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health‐related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension (2017) (54)
- Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals (2020) (53)
- Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure (2020) (52)
- Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure. (2016) (50)
- New Blood Pressure–Associated Loci Identified in Meta-Analyses of 475 000 Individuals (2017) (50)
- Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure. (2018) (49)
- The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study (2011) (49)
- Sex‐specific associations of obesity and N‐terminal pro‐B‐type natriuretic peptide levels in the general population (2018) (47)
- Prognostic value of N‐terminal pro C‐type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction (2014) (47)
- Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction (2018) (46)
- Functional Differences in Engineered Myocardium from Embryonic Stem Cell-Derived versus Neonatal Cardiomyocytes (2013) (46)
- Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes (2018) (44)
- Antioxidant defences in rat, pig, guinea pig, and human hearts: comparison with xanthine oxidoreductase activity. (1993) (43)
- Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment (2019) (41)
- Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials). (2017) (41)
- Clinical importance of urinary sodium excretion in acute heart failure (2020) (40)
- Erythropoietin in the General Population: Reference Ranges and Clinical, Biochemical and Genetic Correlates (2015) (39)
- MicroRNAs relate to early worsening of renal function in patients with acute heart failure. (2016) (38)
- Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure. (2017) (38)
- Omecamtiv mecarbil: a new cardiac myosin activator for the treatment of heart failure (2016) (37)
- Comorbidities in Heart Failure. (2017) (37)
- Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6 (2018) (37)
- Management of vertebral fragility fractures: a clinical care pathway developed by a multispecialty panel using the RAND/UCLA Appropriateness Method. (2018) (36)
- Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure (2016) (36)
- Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH (2017) (35)
- Novel endotypes in heart failure: effects on guideline-directed medical therapy (2018) (35)
- Serum ferritin and risk for new‐onset heart failure and cardiovascular events in the community (2017) (35)
- Dynamics of cerebral blood flow in patients with mild non‐ischaemic heart failure (2017) (35)
- Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humans. (1998) (35)
- Iron deficiency and red cell indices in patients with heart failure (2018) (35)
- Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis (2019) (33)
- Prognostic value of galectin-3, a novel marker of fibrosis (2010) (32)
- Anemia in Heart Failure: Still Relevant? (2018) (31)
- Plasma kidney injury molecule‐1 in heart failure: renal mechanisms and clinical outcome (2016) (29)
- Discovery of novel heart rate-associated loci using the Exome Chip (2017) (29)
- Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: A cross-sectional study. (2017) (29)
- The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure (2019) (28)
- Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction (2017) (28)
- Hyperkalemia and Treatment With RAAS-Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality. (2019) (28)
- The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy (2020) (27)
- Differences in Clinical Profile and Outcomes of Low Iron Storage vs Defective Iron Utilization in Patients With Heart Failure: Results From the DEFINE-HF and BIOSTAT-CHF Studies. (2019) (27)
- Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across sixteen countries (2021) (27)
- Clinical and Hemodynamic Correlates and Prognostic Value of VE/VCO2 Slope in Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Hypertension. (2017) (26)
- Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population (2021) (26)
- Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease (2018) (26)
- Concise Review: The Current State of Human In Vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue Engineering (2018) (26)
- Inflammation and anaemia in a broad spectrum of patients with heart failure (2012) (26)
- Clinical Correlates and Prognostic Value of Proenkephalin in Acute and Chronic Heart Failure. (2017) (25)
- Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure (2017) (25)
- OPLAH ablation leads to accumulation of 5-oxoproline, oxidative stress, fibrosis, and elevated fillings pressures: a murine model for heart failure with a preserved ejection fraction (2018) (25)
- Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial (2022) (25)
- The potential role of valsartan + AHU377 (LCZ696) in the treatment of heart failure (2013) (25)
- Cardio‐Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction (2017) (24)
- ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals (2018) (24)
- Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial (2021) (23)
- Long‐term survivors of early breast cancer treated with chemotherapy are characterized by a pro‐inflammatory biomarker profile compared to matched controls (2020) (23)
- Vitamin B12 and folate deficiency in chronic heart failure (2014) (23)
- Myocardial dysfunction in long‐term breast cancer survivors treated at ages 40–50 years (2019) (22)
- Selenium, Selenoproteins, and Heart Failure: Current Knowledge and Future Perspective (2021) (22)
- Role of Dobutamine Stress Echocardiography for Preoperative Cardiac Risk Assessment Before Major Vascular Surgery: A Diagnostic Tool Comes of Age (2000) (22)
- Cardiomyopathy in patients with epidermolysis bullosa simplex with mutations in KLHL24 (2018) (21)
- A network analysis to identify pathophysiological pathways distinguishing ischaemic from non‐ischaemic heart failure (2020) (20)
- Hyperkalaemia: aetiology, epidemiology, and clinical significance (2019) (20)
- Validity and Predictive Value of a Portable Two-Channel Sleep-Screening Tool in the Identification of Sleep Apnea in Patients With Heart Failure. (2015) (19)
- Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management. (2020) (19)
- Dynamic loading of human engineered heart tissue enhances contractile function and drives a desmosome-linked disease phenotype (2021) (19)
- Daily home BNP monitoring in heart failure for prediction of impending clinical deterioration: results from the HOME HF study (2018) (19)
- Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval (2018) (18)
- Frequency of and Prognostic Significance of Cardiac Involvement at Presentation in Hereditary Transthyretin-Derived Amyloidosis and the Value of N-Terminal Pro-B-Type Natriuretic Peptide. (2018) (18)
- Distinct Pathological Pathways in Patients With Heart Failure and Diabetes. (2020) (18)
- C-reactive protein in the monitoring of acute rejection after heart transplantation (1998) (18)
- Red-light-sensitive BODIPY photoprotecting groups for amines and their biological application in controlling heart rhythm. (2020) (18)
- Usefulness of the ejection fraction response to dobutamine infusion in predicting functional recovery after coronary artery bypass grafting in patients with left ventricular dysfunction. (2000) (18)
- A novel approach to drug development in heart failure: towards personalized medicine. (2014) (18)
- In peripartum cardiomyopathy Plasminogen Activator Inhibitor-1 is a potential new biomarker with controversial roles. (2019) (17)
- The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach (2019) (17)
- Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial. (2021) (17)
- Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases. (2021) (17)
- Cardiac Function After Radiation Therapy for Breast Cancer. (2019) (16)
- A circular RNA derived from the insulin receptor locus protects against doxorubicin-induced cardiotoxicity (2022) (16)
- Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology (2021) (16)
- Erythropoietin: repair of the failing heart. (2006) (15)
- High serum erythropoietin levels are related to heart failure development in subjects from the general population with albuminuria: data from PREVEND (2016) (15)
- A Clinical Tool to Predict Low Serum Selenium in Patients with Worsening Heart Failure (2020) (15)
- Active Smoking and Hematocrit and Fasting Circulating Erythropoietin Concentrations in the General Population (2018) (15)
- Hemoglobin levels and new-onset heart failure in the community. (2015) (15)
- Prevalence, clinical correlates, and outcomes of anaemia in multi‐ethnic Asian patients with heart failure with reduced ejection fraction (2018) (15)
- Mitochondrial Function, Skeletal Muscle Metabolism, and Iron Deficiency in Heart Failure. (2019) (15)
- Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. (2021) (14)
- Diastolic Dysfunction is Common in Survivors of Pediatric Differentiated Thyroid Carcinoma. (2017) (14)
- Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues (2020) (14)
- Gain-of-function mutation in ubiquitin-ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissues. (2021) (14)
- Trajectories of Changes in Renal Function in Patients with Acute Heart Failure. (2019) (13)
- Peripartum cardiomyopathy: Euro Observational Research Program (2014) (13)
- Dynamic Loading of Human Engineered Heart Tissue Enhances Contractile Function and Drives Desmosome-linked Disease Phenotype (2020) (13)
- Heart failure in the young. (2013) (12)
- Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy (2021) (12)
- LC‐MS analysis of key components of the glutathione cycle in tissues and body fluids from mice with myocardial infarction (2018) (12)
- Erythropoietin in cardiovascular diseases: exploring new avenues. (2008) (12)
- Associations of Body Mass Index With Laboratory and Biomarkers in Patients With Acute Heart Failure (2017) (12)
- Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial (2022) (11)
- Cardiac foetal reprogramming: a tool to exploit novel treatment targets for the failing heart (2020) (11)
- Cardiotoxicity of breast cancer treatment: no easy solution for an important long-term problem. (2016) (11)
- Acute heart failure in the young: Clinical characteristics and biomarker profiles. (2016) (11)
- Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure (PUSH‐AHF) trial (2021) (11)
- Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial (2017) (10)
- Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure): Clinical and Prognostic Associations (2018) (10)
- Genetic Determinants of Electrocardiographic P-Wave Duration and Relation to Atrial Fibrillation (2020) (10)
- Meta-GWAS and Meta-Analysis of Exome Array Studies Do Not Reveal Genetic Determinants of Serum Hepcidin (2016) (10)
- Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study (2019) (10)
- Anaemia and renal dysfunction in chronic heart failure (2009) (10)
- Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism? (2022) (9)
- High selenium levels associate with reduced risk of mortality and new‐onset heart failure: data from PREVEND (2021) (9)
- Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy: results from the ESC EORP PPCM registry (2021) (9)
- Effect of adopting a new histological grading system of acute rejection after heart transplantation (1997) (9)
- Captopril inhibits angiotensin I-induced coronary flow reduction in isolated rat heart but has no effect on contractility or energy metabolism. (1992) (8)
- Anaemia predicts cardiovascular events in patients with stable coronary artery disease. (2005) (8)
- Prehospital risk stratification in patients with chest pain (2021) (8)
- Genetic risk and atrial fibrillation in patients with heart failure (2020) (8)
- Impact of sex-specific target dose in chronic heart failure patients with reduced ejection fraction. (2020) (7)
- Value of digoxin in patients with heart failure: new pieces to the puzzle (2018) (7)
- Plasma levels of alpha-1-antichymotrypsin are elevated in patients with chronic heart failure, but are of limited prognostic value (2014) (7)
- Pathophysiology and risk factors of peripartum cardiomyopathy (2022) (7)
- Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry (2021) (7)
- Asialoerythropoietin to protect the failing heart: is it possible to run with the hare and hunt with the hounds? (2010) (7)
- Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)–Related Cardiomyopathy: Development of PLN-R14del–Related Cardiomyopathy (2021) (6)
- ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca2+ Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ (2021) (6)
- Iron deficiency in heart failure-time to redefine. (2020) (6)
- Inosine transiently decreases coronary flow but potentiates vasodilation by adenosine. (1990) (6)
- Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy (2018) (6)
- N‐terminal pro‐B‐type natriuretic peptide and prognosis in Caucasian vs. Asian patients with heart failure (2018) (6)
- Associations between volume status and circulating microRNAs in acute heart failure (2017) (6)
- Selenoprotein DIO2 Is a Regulator of Mitochondrial Function, Morphology and UPRmt in Human Cardiomyocytes (2021) (6)
- Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction (2021) (6)
- Immune checkpoint inhibitor–associated myocarditis (2022) (6)
- Human iPSC-Derived Cardiomyocytes of Peripartum Patients With Cardiomyopathy Reveal Aberrant Regulation of Lipid Metabolism (2020) (6)
- Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myocardial infarction: a meta-analysis of individual patient data. (2014) (5)
- Active smoking and macrocytosis in the general population: Two population‐based cohort studies (2018) (5)
- Cardiac ATP breakdown and mechanical function during recurrent periods of anoxia. (1992) (5)
- Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after ST-segment Elevation Myocardial Infarction (GIPS-IV) Trial. (2021) (5)
- Does xanthine oxidase cause damage during myocardial ischemia? (1991) (5)
- Single-Cell Functional Analysis of Stem-Cell Derived Cardiomyocytes on Micropatterned Flexible Substrates. (2017) (5)
- Sleep‐disordered breathing and chronic heart failure: changing position may be important (2015) (5)
- Clinical implications of low estimated protein intake in patients with heart failure (2022) (4)
- Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (2020) (4)
- Additional burden of iron deficiency in heart failure patients beyond the cardio‐renal anaemia syndrome: findings from the BIOSTAT‐CHF study (2021) (4)
- Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction (2021) (4)
- Job insecurity and mental health (4)
- Erythropoiesis-stimulating agents and heart failure. (2011) (4)
- Acute coronary syndromes: the unfulfilled promise of erythropoietin in patients with MI. (2011) (4)
- Residual confounding in observational studies: new data from the old DIG trial. (2019) (4)
- Prevention and treatment of ischemic injury with nucleosides. (1991) (4)
- Optimal Timing of a Physical Exercise Intervention to Improve Cardiorespiratory Fitness (2022) (4)
- The Additive Prognostic Value of Serial Plasma Interleukin-6 Levels over Changes in Brain Natriuretic Peptide in Patients with Acute Heart Failure. (2021) (3)
- Pathophysiological pathways in patients with heart failure and atrial fibrillation (2021) (3)
- Pharmacotherapy for comorbidities in chronic heart failure: a focus on hematinic deficiencies, diabetes mellitus and hyperkalemia (2016) (3)
- Physical Activity and Cardiac Function in Long-Term Breast Cancer Survivors (2022) (3)
- Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How? (2022) (3)
- Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure? (2022) (3)
- Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy (2022) (3)
- Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure (2020) (3)
- Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF (2021) (3)
- Effects of inosine and adenine on nucleotide levels in the post-ischemic rat heart, perfused with and without pyruvate. (1990) (3)
- Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation (2022) (3)
- Longitudinal changes in circulating ketone body levels in patients with acute heart failure: A post-hoc analysis of the EMPA-Response-AHF Trial. (2022) (3)
- Review: Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14del (2022) (2)
- To bind or not to bind: potassium-lowering drugs in heart failure. (2011) (2)
- Impact of sex-specific target dose in chronic heart failure patients with reduced ejection fraction. (2021) (2)
- Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction? (2019) (2)
- A deleterious interaction between omecamtiv mecarbil and atrial fibrillation in patients with heart failure: an influence of digoxin? (2022) (2)
- Comorbidities complicating heart failure: changes over the last 15 years (2022) (2)
- Effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure (2021) (2)
- Anemia is associated with an increased central venous pressure and mortality in a broad spectrum of cardiovascular patients (2014) (2)
- Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6 (2018) (1)
- Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapies (2022) (1)
- Sexual dimorphism in selenium deficiency is associated with metabolic syndrome and prevalence of heart disease (2023) (1)
- Response: A Portable Device as Sleep-Screening Tool in the Identification of Obstructive Sleep Apnea in Chronic Heart Failure: Which Value Should We Consider as Cutoff? (2016) (1)
- Sleep-disordered Breathing in Heart Failure - Current State of the Art. (2014) (1)
- Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals (2020) (1)
- [New applications of erythropoietin in cardiovascular disease: from haematopoiesis to cardiac protection]. (2008) (1)
- A translation re‐initiation variant in KLHL24 also causes epidermolysis bullosa simplex and dilated cardiomyopathy via intermediate filament degradation (2022) (1)
- Functional investigation of two simultaneous or separately segregating DSP variants within a single family supports the theory of a dose‐dependent disease severity (2022) (1)
- ATTR Amyloidosis: development of cardiac symptoms during 6 years of follow up in different ATTR-variants (2015) (1)
- [Parenteral iron therapy in chronic kidney disease or chronic heart failure]. (2015) (1)
- Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure (2020) (0)
- Socio-economic factors determine maternal and noenatal outcomes in women with peripartum cardiomyopathy: a study of the ESC EORP PPCM registry (2022) (0)
- Heart failure with normal LVEF in BIOSTAT-CHF. (2022) (0)
- Urinary sodium evaluation: the missing target for diuretic treatment optimization in acute heart failure patients? Reply (2020) (0)
- Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction. (2023) (0)
- Anemia and erythropoietin in heart failure. (2008) (0)
- Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure. (2023) (0)
- Exploratory proteome profiling in patients with peripartum cardiomyopathy – a biomarker study on the EORP cohort (2022) (0)
- The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial (2022) (0)
- Progressive Diastolic Dysfunction in Survivors of Pediatric Differentiated Thyroid Carcinoma. (2022) (0)
- The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (2020) (0)
- Severe early-onset cardiomyopathy and poor prognosis observed in 73 patients with pathogenic KLHL24 variants (2022) (0)
- IGF-1 boosts mitochondrial function by a Ca2+ uptake-dependent mechanism in cultured human and rat cardiomyocytes (2023) (0)
- Sacubitril/valsartan compared to ramipril in high risk post myocardial infarction patients stratified according use of mineralocorticoid receptor antagonists: insight from PARADISE MI trial (2022) (0)
- Selenium deficiency is associated with new-onset atrial fibrillation in PREVEND: a prospective general population cohort (2022) (0)
- Predicting heart failure: one size does not fit all (2018) (0)
- Genetically Determined High Levels of Iron Parameters Are Protective for Coronary Artery Disease. (2020) (0)
- Towards a Better Understanding of Genotype–Phenotype Correlations and Therapeutic Targets for Cardiocutaneous Genes: The Importance of Functional Studies above Prediction (2022) (0)
- Anemia and congestive heart failure. (2003) (0)
- Effect of Intravenous Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation (EFFECT-KTx): rationale and study protocol for a double-blind, randomised, placebo-controlled trial (2023) (0)
- Micronutrient deficiencies and new-onset atrial fibrillation in a community-based cohort: data from PREVEND (2022) (0)
- ATPase Inhibitor Factor-1 Disrupts Mitochondrial Ca2+ Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδ (2021) (0)
- Geographic Differences in Patients With Acute Myocardial Infarction in The PARADISE-MI Trial. (2023) (0)
- Thrombo-embolic events in peripartum cardiomyopathy: results from the ESC EORP PPCM registry. (2023) (0)
- Publisher Correction: Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals (2021) (0)
- Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis. (2023) (0)
- An Erythropoietin-Independent Mechanism of Erythrocytic Precursor Proliferation Underlies Hypoxia Tolerance in Sea Nomads (2022) (0)
- Neuromodulation for systolic heart failure: more than a placebo effect? (2017) (0)
- Diagnostic accuracy of the electrocardiogram for heart failure with reduced or preserved ejection fraction. (2023) (0)
- Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy (2018) (0)
This paper list is powered by the following services:
